Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study

Por Sheldon, Eric A., Jeanfreau, Robert, Sliman, Joseph A., Charenkavanich, Supoat, Rousculp, Matthew D., Dubovsky, Filip, Mallory, Raburn M.
Publicado no Influenza Other Respir Viruses (2012)

AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

Por Kosalaraksa, Pope, Jeanfreau, Robert, Frenette, Louise, Drame, Mamadou, Madariaga, Miguel, Innis, Bruce L., Godeaux, Olivier, Izurieta, Patricia, Vaughn, David W.
Publicado no J Infect Dis (2015)

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

Por Pavia-Ruz, Noris, Angel Rodriguez Weber, Miguel, Lau, Yu-Lung, Nelson, E Anthony S, Kerdpanich, Angkool, Huang, Li-Min, Silas, Peter, Qaqundah, Paul, Blatter, Mark, Jeanfreau, Robert, Lei, Paul, Jain, Varsha, El Idrissi, Mohamed, Feng, Yang, Innis, Bruce, Peeters, Mathieu, Devaster, Jeanne-Marie
Publicado em 2013